Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Masato Uetani

2PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Dec 22, 2025
Successful Combination Therapy With Lenvatinib Plus Pembrolizumab for Rare Case of Advanced Renal Cell Carcinoma With Ocular Adnexal Metastasis.

Yozo Mitsui, Masato Uetani, Fumito Yamabe

|Oct 18, 2025
Inflammatory Markers in Combination With Multiple Patterns of Extrarenal Extension Accurately Indicate Recurrence Risk in Patients With pT3aN0M0 Clear Cell Renal Cell Carcinoma.

Masato Uetani, Fumito Yamabe, Shunsuke Hori

Pageof 1

Frequent Collaborators

2 joint publications

Hideyuki Kobayashi

2 joint publications

Yozo Mitsui

1 joint publications

Mizuki Kasahara

1 joint publications

Fumito Yamabe

1 joint publications

Naobumi Tochigi

1 joint publications

Koichi Nakajima

Frequent Collaborators

2 joint publications

Hideyuki Kobayashi

2 joint publications

Yozo Mitsui

1 joint publications

Mizuki Kasahara

1 joint publications

Fumito Yamabe

Top Related Videos

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on : Sep 25, 2018

10.9K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1<sup>+</sup> Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1<sup>+</sup> Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells

Published on : Feb 08, 2018

15.3K
See more related videos

Top Related Videos

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on : Sep 25, 2018

10.9K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1<sup>+</sup> Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1<sup>+</sup> Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells

Published on : Feb 08, 2018

15.3K
See more related videos